Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3780960rdf:typepubmed:Citationlld:pubmed
pubmed-article:3780960lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:3780960lifeskim:mentionsumls-concept:C0205464lld:lifeskim
pubmed-article:3780960pubmed:issue9lld:pubmed
pubmed-article:3780960pubmed:dateCreated1986-12-29lld:pubmed
pubmed-article:3780960pubmed:abstractTextFive 1-lupinyl-3R'-6R"-quinoxalin-2(1H)-ones were tested in mice for acute toxicity, explorative activity inhibition, analgesic activity and for antagonism against physostigmine, strychnine and pentylentetrazol (cardiazol). As reference compounds were used chloropromazine, morphine, atropine and diazepam respectively. All tested compounds inhibit the explorative activity and exhibit high analgesic activity. Compound (I) protects completely the animals from physostigmine toxicity, while compound (IV) antagonizes, although only slightly, all the toxicants tested.lld:pubmed
pubmed-article:3780960pubmed:languageitalld:pubmed
pubmed-article:3780960pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3780960pubmed:citationSubsetIMlld:pubmed
pubmed-article:3780960pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3780960pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3780960pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3780960pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3780960pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3780960pubmed:statusMEDLINElld:pubmed
pubmed-article:3780960pubmed:monthSeplld:pubmed
pubmed-article:3780960pubmed:issn0430-0920lld:pubmed
pubmed-article:3780960pubmed:authorpubmed-author:SattaMMlld:pubmed
pubmed-article:3780960pubmed:authorpubmed-author:AlamanniM CMClld:pubmed
pubmed-article:3780960pubmed:authorpubmed-author:PeanaAAlld:pubmed
pubmed-article:3780960pubmed:authorpubmed-author:SparatoreAAlld:pubmed
pubmed-article:3780960pubmed:issnTypePrintlld:pubmed
pubmed-article:3780960pubmed:volume41lld:pubmed
pubmed-article:3780960pubmed:ownerNLMlld:pubmed
pubmed-article:3780960pubmed:authorsCompleteYlld:pubmed
pubmed-article:3780960pubmed:pagination722-8lld:pubmed
pubmed-article:3780960pubmed:dateRevised2009-6-5lld:pubmed
pubmed-article:3780960pubmed:meshHeadingpubmed-meshheading:3780960-...lld:pubmed
pubmed-article:3780960pubmed:meshHeadingpubmed-meshheading:3780960-...lld:pubmed
pubmed-article:3780960pubmed:meshHeadingpubmed-meshheading:3780960-...lld:pubmed
pubmed-article:3780960pubmed:meshHeadingpubmed-meshheading:3780960-...lld:pubmed
pubmed-article:3780960pubmed:meshHeadingpubmed-meshheading:3780960-...lld:pubmed
pubmed-article:3780960pubmed:meshHeadingpubmed-meshheading:3780960-...lld:pubmed
pubmed-article:3780960pubmed:meshHeadingpubmed-meshheading:3780960-...lld:pubmed
pubmed-article:3780960pubmed:meshHeadingpubmed-meshheading:3780960-...lld:pubmed
pubmed-article:3780960pubmed:meshHeadingpubmed-meshheading:3780960-...lld:pubmed
pubmed-article:3780960pubmed:meshHeadingpubmed-meshheading:3780960-...lld:pubmed
pubmed-article:3780960pubmed:meshHeadingpubmed-meshheading:3780960-...lld:pubmed
pubmed-article:3780960pubmed:year1986lld:pubmed
pubmed-article:3780960pubmed:articleTitle[Pharmacologic activity of 1-lupinylquinoxalin-2(1H)-ones, 3,6-disubstituted].lld:pubmed
pubmed-article:3780960pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3780960pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:3780960pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed